cA2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for cA2, covering 2009-07-21 to 2009-07-21. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Korean Patients With Active Rheumatoid Arthritis Despite Methorexate (Extension Part)(Study P05645)(COMPLETED) [Phase 3]